Avidity Partners Management LP Clovis Oncology, Inc. Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $1.1 Million - $1.58 Million	-271,726 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $1.36 Million - $1.92 Million	271,726 New	271,726 $1.58 Million
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $4.13 Million - $6.41 Million	-1,000,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $4.82 Million - $7.72 Million	1,000,000 New	1,000,000 $5.83 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.